BIG DATA ANALYSIS FOR BIOINFORMATICS AND BIOMEDICAL DISCOVERIES

BIG DATA ANALYSIS FOR BIOINFORMATICS AND BIOMEDICAL DISCOVERIES

Editorial:
CRC PRESS
Año de edición:
Materia
Matematicas
ISBN:
978-1-4987-2452-4
Páginas:
274
N. de edición:
1
Idioma:
Inglés
Ilustraciones:
23
Disponibilidad:
Disponible en 2-3 semanas

Descuento:

-5%

Antes:

105,00 €

Despues:

99,75 €

• Commonly Used Tools for Big Data Analysis
Linux for Big Data Analysis
Shui Qing Ye and Ding-You Li
Python for Big Data Analysis
Dmitry N. Grigoryev
R for Big Data Analysis
Stephen D. Simon
• Next-Generation DNA Sequencing Data Analysis
Genome-Seq Data Analysis
Min Xiong, Li Qin Zhang, and Shui Qing Ye
RNA-Seq Data Analysis
Li Qin Zhang, Min Xiong, Daniel P. Heruth, and Shui Qing Ye
Microbiome-Seq Data Analysis
Daniel P. Heruth, Min Xiong, and Xun Jiang
miRNA-Seq Data Analysis
Daniel P. Heruth, Min Xiong, and Guang-Liang Bi
Methylome-Seq Data Analysis
Chengpeng Bi
ChIP-Seq Data Analysis
Shui Qing Ye, Li Qin Zhang, and Jiancheng Tu
• Integrative and Comprehensive Big Data Analysis
Integrating Omics Data in Big Data Analysis
Li Qin Zhang, Daniel P. Heruth, and Shui Qing Ye
Pharmacogenetics and Genomics
Andrea Gaedigk, Katrin Sangkuhl, and Larisa H. Cavallari
Exploring De-Identified Electronic Health Record Data with i2b2
Mark Hoffman
Big Data and Drug Discovery
Gerald J. Wyckoff and D. Andrew Skaff
Literature-Based Knowledge Discovery
Hongfang Liu and Majid Rastegar-Mojarad
Mitigating High Dimensionality in Big Data Analysis
Deendayal Dinakarpandian

Big Data Analysis for Bioinformatics and Biomedical Discoveries provides a practical guide to the nuts and bolts of Big Data, enabling you to quickly and effectively harness the power of Big Data to make groundbreaking biological discoveries, carry out translational medical research, and implement personalized genomic medicine. Contributing to the NIH Big Data to Knowledge (BD2K) initiative, the book enhances your computational and quantitative skills so that you can exploit the Big Data being generated in the current omics era.
The book explores many significant topics of Big Data analyses in an easily understandable format. It describes popular tools and software for Big Data analyses and explains next-generation DNA sequencing data analyses. It also discusses comprehensive Big Data analyses of several major areas, including the integration of omics data, pharmacogenomics, electronic health record data, and drug discovery.
Accessible to biologists, biomedical scientists, bioinformaticians, and computer data analysts, the book keeps complex mathematical deductions and jargon to a minimum. Each chapter includes a theoretical introduction, example applications, data analysis principles, step-by-step tutorials, and authoritative references.

Features
• Covers the most important topics of Big Data analysis in biomedicine and biology
• Introduces computing tools for Big Data analysis, such as Linux-based command lines, Python, and R
• Presents data analysis pipelines for next-generation DNA sequencing applications, including Genome-seq, RNA-seq, Microbiome-seq, Methylome-seq, miRNA-seq, and ChIP-seq
• Shows how to integrate high-dimensional omics data, pharmacogenomics data, electronic medical records, in silico drug findings, and literature-based knowledge for precision medicine

Author
Shui Qing Ye, MD, PhD, is the William R. Brown/Missouri Endowed Chair in Medical Genetics and Molecular Medicine and a tenured full professor in biomedical and health informatics and pediatrics at the University of Missouri–Kansas City School of Medicine. He is also the director of the Division of Experimental and Translational Genetics in the Department of Pediatrics and director of the Core of Omics Research at The Children’s Mercy Hospital. Dr. Ye has been involved with biomedical research for more than 30 years. His current research interests include the application of translational bioinformatics to leverage Big Data to make biological discoveries and gain new, unifying global biological insights, which may lead to the development of new diagnostic and therapeutic targets for human diseases.